XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

NCT04926545 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Malignant Tumor
Diarrhea

Interventions

DRUG: Xiao Chai Hu Tang (XCHT)
OTHER: Raloxifene
DRUG: FOLFIRI regimen

Sponsor

Guangzhou University of Traditional Chinese Medicine

Collaborators

[object Object]